http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a2f1906c5e07994c695cf2ab689c1a26
Outgoing Links
Predicate | Object |
---|---|
family-name | Crossley |
name | Merlin Crossley |
given-name | Merlin |
organization-name | School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW 2052, Australia. School of Molecular and Microbial Biosciences, University of Sydney, Sydney, New South Wales, Australia School of Biotechnology and Biomolecular Sciences, University of New South Wales, 2052 Sydney, Australia School of Biotechnology and Biomolecular Sciences, University of New South Wales, Kensington, Australia School of Biotechnology and Biomolecular Sciences, University of New South Wales School of Biotechnology and Biomolecular Sciences University of New South Wales Kensington Australia School of Molecular and Microbial Biosciences, University of Sydney, Sydney, New South Wales 2006, Australia Chemical Pathology Unit, Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom. School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW, Australia and School of Molecular Bioscience, University of Sydney, Sydney, NSW, Australia; Division of Hematology-Oncology, Children's Hospital and Dana-Farber Cancer Institute, Department of Pediatrics, Harvard Medical School, Boston, Massachusetts 02115 School of Molecular and Microbial Biosciences, G08, University of Sydney, Sydney, NSW 2006, Australia From the Puget Sound Blood Center and Program, Seattle, WA; the Division of Hematology, University of Washington, Seattle; and the Department of Biochemistry, University of Sydney, Australia. School of Molecular and Microbial Biosciences, University of Sydney, Sydney, NSW 2006, Australia *School of Molecular Bioscience, University of Sydney, Sydney, New South Wales 2006, Australia;; ‡School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, New South Wales 2052, Australia; School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, New South Wales, Australia School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW 2052, Australia Division of Hematology-Oncology, Children’s Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115 School of Biotechnology and Biomolecular Sciences UNSW Sydney Sydney NSW 2052 Australia Australia, and Division of Hematology/Oncology, Children's Hospital, Dana-Farber Cancer Institute and Department of Pediatrics, Harvard Medical School, and Howard Hughes Medical Institute, Boston, Massachusetts 02115 Author affiliations are listed in the supplementary materials. School of Biotechnology and Biomolecular Sciences, University of New South Wales (UNSW Sydney), Sydney, NSW, Australia; School of Molecular and Microbial Biosciences, Biochemistry Building G08, University of Sydney, Sydney, New South Wales 2006, Australia School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW, Australia; School of Molecular and Microbial Biosciences, University of Sydney, Sydney, Australia School of Molecular and Microbial Biosciences G08, University of Sydney Sydney NSW 2006 Australia School of Molecular and Microbial Biosciences, G08, University of Sydney, Sydney, New South Wales 2006, Australia |
Incoming Links
Total number of triples: 145.